NEXTHERA CAPITAL LP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 120 filers reported holding CARA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.01 and the average weighting 0.5%.

Quarter-by-quarter ownership
NEXTHERA CAPITAL LP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$17,658,000
+111.6%
737,303
+69.2%
3.38%
+161.9%
Q2 2018$8,346,000
+92.0%
435,800
+24.1%
1.29%
+80.4%
Q1 2018$4,346,000
+93.9%
351,050
+141.1%
0.72%
-26.6%
Q2 2017$2,241,000
-37.5%
145,600
-25.3%
0.98%
-46.7%
Q1 2017$3,586,000
+54.4%
195,000
-22.0%
1.83%
+34.4%
Q4 2016$2,323,000250,0001.36%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Ridgeback Capital Investments L.P. 622,140$10,489,00045.13%
RHO CAPITAL PARTNERS INC 2,668,057$44,983,00015.47%
Opaleye Management Inc. 427,000$7,199,0003.01%
DAFNA Capital Management LLC 169,331$2,855,0002.54%
Private Capital Advisors, Inc. 246,850$4,162,0001.80%
WALL STREET ASSOCIATES 192,300$3,242,0000.91%
SECTORAL ASSET MANAGEMENT INC 1,212,578$20,444,0000.87%
Virtus ETF Advisers LLC 17,299$292,0000.80%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 618,140$10,422,0000.58%
SPHERA FUNDS MANAGEMENT LTD. 197,820$3,335,0000.49%
View complete list of CARA THERAPEUTICS INC shareholders